FIGURE LEGEND
FIGURE 1 (A) Drop in CNS leukemic blast count and patient weight after initiation of therapy (top); diagram of therapy provided (bottom). ITT, intra-thecal triple therapy; Cyt, intrathecal cytarabine; Cyt/HC, intrathecal cytarabine and hydrocortisone; DEX, dexamethasone; 6-MP, 6-mercaptopurine; VCR, vincristine. (B) Growth curve for the patient showing rapid weight gain over a six-month period, with resolution once CNS-directed therapy was initiated.